Samuel Oji Oti

Samuel Oji Oti

Auto-generated profile, based on publicly available information

Samuel Oji Oti

Affiliation Global Health Decolonisation Movement in Africa, Nairobi, Kenya

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SMSamuel Muhula
Samuel Muhula
AMAnthony Mveyange
Anthony Mveyange
SOSamuel Oji Oti
Samuel Oji Oti
MBMartha Bande
Martha Bande
HKHellen Kayiaa
Hellen Kayiaa
HCHilke Conradi
Hilke Conradi
Introduction: In Kenya, Female Genital Mutilation/Cutting (FGM/C) is highly prevalent in specific communities such as the Maasai and Somali. With the intention of curtailing FMG/C prevalence in Maasai community, Amref Health Africa, designed and implemented a novel intervention—community-led alternative rite of passage (CLARP) in Kajiado County in Kenya since 2009. The study: a) determined the impact of the CLARP model on FGM/C, child early and forced marriages (CEFM), teenage pregnancies (TP) and years of schooling among girls and b) explored the attitude, perception and practices of community stakeholders towards FGM/C. Methods: We utilised a mixed methods approach. A difference-in-difference approach was used to quantify the average impact of the model with Kajiado as the intervention County and Mandera, Marsabit and Wajir as control counties. The approach relied on secondary data analysis of the Kenya Demographic and Health Survey (KDHS) 2003, 2008–2009 and 2014. A qualitative approach involving focus group discussions, in-depth interviews and key informant interviews were conducted with various respondents and community stakeholders to document experiences, attitude and practices towards FGM/C. Results: The CLARP has contributed to: 1) decline in FGM/C prevalence, CEFM rates and TP rates among girls by 24.2% (p<0.10), 4.9% (p<0.01) and 6.3% (p<0.01) respectively. 2) increase in girls schooling years by 2.5 years (p<0.05). Perceived CLARP benefits to girls included: reduction in teenage marriages and childbirth; increased school retention and completion; teenage pregnancies reduction and decline in FGM/C prevalence. Community stakeholders in Kajiado believe that CLARP has been embraced in the community because of its impacts in the lives of its beneficiaries and their families. Conclusion: This study demonstrated that CLARP has been positively received by the Maasai community and has played a significant role in attenuating FGM/C, CEFM and TP in Kajiado, while contributing to increasing girls’ schooling years. CLARP is replicable as it is currently being implemented in Tanzania. We recommend scaling it up for adoption by stakeholders implementing in other counties that practice FGM/C as a rite of passage in Kenya and across other sub Saharan Africa countries.

26 April 2016 in Bulletin of the World Health Organization
Verified
Journal Article
Open access
SOSamuel Oji Oti
Samuel Oji Oti
SVSteven van de Vijver
Steven van de Vijver
GGGabriela B Gomez
Gabriela B Gomez
CACharles Agyemang
Charles Agyemang
TEThaddaeus Egondi
Thaddaeus Egondi
KSKarien Stronks
Karien Stronks
To describe the processes, outcomes and costs of implementing a multi-component, community-based intervention for hypertension among adults aged > 35 years in a large slum in Nairobi, Kenya. The intervention in 2012-2013 was based on four components: awareness-raising; improved access to screening; standardized clinical management of hypertension; and long-term retention in care. Using multiple sources of data, including administrative records and surveys, we described the inputs and outputs of each intervention activity and estimated the outcomes of each component and the impact of the intervention. We also estimated the costs associated with implementation, using a top-down costing approach. The intervention reached 60% of the target population (4049/6780 people), at a cost of 17 United States dollars (US$) per person screened and provided access to treatment for 68% (660/976) of people referred, at a cost of US$ 123 per person with hypertension who attended the clinic. Of the 660 people who attended the clinic, 27% (178) were retained in care, at a cost of US$ 194 per person retained; and of those patients, 33% (58/178) achieved blood pressure control. The total intervention cost per patient with blood pressure controlled was US$ 3205. With moderate implementation costs, it was possible to achieve hypertension awareness and treatment levels comparable to those in high-income settings. However, retention in care and blood pressure control were challenges in this slum setting. For patients, the costs and lack of time or forgetfulness were barriers to retention in care.

24 March 2016 in Global Health Action
Verified
Journal Article
Open access
SVSteven Vijver
Steven Vijver
SOSamuel Oji Oti
Samuel Oji Oti
GGGabriela B. Gomez
Gabriela B. Gomez
Charles AgyemangCharles Agyemang
Charles Agyemang
TEThaddaeus Egondi
Thaddaeus Egondi
KSKarien Stronks
Karien Stronks
BackgroundA combination of increasing urbanization, behaviour change, and lack of health services in slums put the urban poor specifically at risk of cardiovascular disease (CVD). This study aimed ...

4 January 2021 in Annals of Global Health
Verified
Journal Article
Open access
PDF file
KMKibachio Mwangi
Kibachio Mwangi
GGGladwell Gathecha
Gladwell Gathecha
MNMary Nyamongo
Mary Nyamongo
SKSylvester Kimaiyo
Sylvester Kimaiyo
JKJemima Kamano
Jemima Kamano
NGNeil Gupta
Neil Gupta
Kenya has implemented a robust response to non-communicable diseases and injuries (NCDIs); however, key gaps in health services for NCDIs still exist in the attainment of Universal Health Coverage (UHC). The Kenya Non-Communicable Diseases and Injury (NCDI) Poverty Commission was established to estimate the burden of NCDIs, determine the availability and coverage of health services, prioritize an expanded set of NCDI conditions, and propose cost-effective and equity-promoting interventions to avert the health and economic consequences of NCDIs in Kenya. Burden of NCDIs in Kenya was determined using desk review of published literature, estimates from the Global Burden of Disease Study, and secondary analysis of local health surveillance data. Secondary analysis of nationally representative surveys was conducted to estimate current availability and coverage of services by socioeconomic status. The Commission then conducted a structured priority setting process to determine priority NCDI conditions and health sector interventions based on published evidence. There is a large and diverse burden of NCDIs in Kenya, with the majority of disability-adjusted life-years occurring before age of 40. The poorest wealth quintiles experience a substantially higher deaths rate from NCDIs, lower coverage of diagnosis and treatment for NCDIs, and lower availability of NCDI-related health services. The Commission prioritized 14 NCDIs and selected 34 accompanying interventions for recommendation to achieve UHC. These interventions were estimated to cost $11.76 USD per capita annually, which represents 15% of current total health expenditure. This investment could potentially avert 9,322 premature deaths per year by 2030. An expanded set of priority NCDI conditions and health sector interventions are required in Kenya to achieve UHC, particularly for disadvantaged socioeconomic groups. We provided recommendations for integration of services within existing health services platforms and financing mechanisms and coordination of whole-of-government approaches for the prevention and treatment of NCDIs.

27 February 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
CKCatherine Kyobutungi
Catherine Kyobutungi
GGGithinji Gitahi
Githinji Gitahi
MWMarie-Claire Wangari
Marie-Claire Wangari
PSPatterson Siema
Patterson Siema
EGEvelyn Gitau
Evelyn Gitau
SOSamuel Oji Oti
Samuel Oji Oti
Global health evolved from colonial medicine and hence deeply rooted in the white supremacy mindset [1]. Anti-Blackness is an inescapable consequence. Definitions of anti-Blackness revolve around the positioning of Black people, their cultural practices and knowledge as inferior, the conscious and unconscious dehumanization and discrimination of Black bodies, a disdain for Black people and their lived experiences, the disenfranchisement of Black people, but above all, a system of beliefs and practices that erode their humanity. In a recent event held in Nairobi, Kenya, we discussed what anti-Blackness in global health means, why it matters, and what needs to be done to counter anti-Blackness in global health and development [2]. How does anti-Blackness manifest itself? No continent has been more impacted by the ravages of colonialism and racism than the African continent. Sadly, even today, Africans are at the receiving end of discrimination, from vaccine apartheid to visa apartheid. The Covid-19 pandemic offers a stunning recent example of anti-Blackness. No continent is less vaccinated and boosted than the African continent [3]. While wealthy nations rushed to clean up the shelves, hoard vaccines, and even throw away millions of expired vaccines, the African region was left last in the line. Despite the efforts of activists and the support of most countries, a few rich countries blocked the TRIPS waiver that could have significantly expanded vaccine manufacturing in the Global South. Two years after vaccination began in wealthy nations, and even as second and third booster shots are being offered in the Global North, barely one in four people in the African region are vaccinated with two doses (as of January 2023) [3]. The African region has also had the lowest Covid-19 testing rate, and access to anti-viral medications such as Paxlovid is practically non-existent. This pattern of discrimination is not new. More than 30 years ago, when anti-retrovirals (ARV) became available, they were considered too expensive to roll-out in the African region. As late as 2001, some experts maintained that ARV treatment in Sub-Saharan Africa was impossible. It took incredible activism, legal action, and community effort before they started becoming available, by which time millions of Africans got infected and died. When the Ebola outbreak ravaged West Africa during 2014-16, it killed more than 11,000 people in Guinea, Liberia, and Sierra Leone. Even intravenous hydration was seen as being too challenging during this crisis. While an overwhelming majority of the mostly White American and European healthcare workers who contracted Ebola survived, the infection killed two-PLOS GLOBAL PUBLIC HEALTH

18 March 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
SOSamuel Oji Oti
Samuel Oji Oti